1. Masking for COVID-19 and other respiratory viral infections: implications of the available evidence
- Author
-
Halperin, Daniel T, Doron, Shira, Hodgins, Stephen, Bailey, Robert C, Baral, Stefan, Bhatia, Rajiv, Noble, Jeanne, Gandhi, Monica, and Hearst, Norman
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Lung ,Prevention ,Infectious Diseases ,Clinical Trials and Supportive Activities ,Emerging Infectious Diseases ,Clinical Research ,Infection ,Good Health and Well Being - Abstract
The use of face masks has been widely promoted and at times mandated to prevent coronavirus disease 2019 (COVID-19). The 2023 publication of an updated Cochrane review on mask effectiveness for respiratory viruses as well as the unfolding epidemiology of COVID-19 underscore the need for an unbiased assessment of the current scientific evidence. It appears that the widespread promotion, adoption, and mandating of masking for COVID-19 were based not primarily on the strength of evidence for effectiveness but more on the imperative of decision-makers to act in the face of a novel public health emergency, with seemingly few good alternatives. Randomized clinical trials of masking for prevention of COVID-19 and other respiratory viruses have so far shown no evidence of benefit (with the possible exception of continuous use of N95 respirators by hospital workers). Observational studies provide lower-quality evidence and do not convincingly demonstrate benefit from masking or mask mandates. Unless robust new evidence emerges showing the effectiveness of masks in reducing infection or transmission risks in either trials or real-world conditions, mandates are not warranted for future epidemics of respiratory viral infections.
- Published
- 2024